Detalhe da pesquisa
1.
Incidence, treatment and survival of malignant pleural and peritoneal mesothelioma: a population-based study.
Thorax
; 77(12): 1260-1267, 2022 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-35149582
2.
OX40 agonism enhances PD-L1 checkpoint blockade by shifting the cytotoxic T cell differentiation spectrum.
Cell Rep Med
; 4(3): 100939, 2023 03 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-36796366
3.
Hydrogen cyanide emission in the lung by Staphylococcus aureus.
Eur Respir J
; 48(2): 577-9, 2016 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-27230439
4.
High-intensity statins are associated with improved clinical activity of PD-1 inhibitors in malignant pleural mesothelioma and advanced non-small cell lung cancer patients.
Eur J Cancer
; 144: 41-48, 2021 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-33326868
5.
Ki67 (MIB-1) as a Prognostic Marker for Clinical Decision Making Before Extended Pleurectomy Decortication in Malignant Pleural Mesothelioma.
JTO Clin Res Rep
; 2(4): 100155, 2021 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-34590009
6.
Cellular Immunotherapy and Locoregional Administration of CAR T-Cells in Malignant Pleural Mesothelioma.
Front Oncol
; 10: 777, 2020.
Artigo
em Inglês
| MEDLINE | ID: mdl-32582537
7.
Nivolumab in pre-treated malignant pleural mesothelioma: real-world data from the Dutch expanded access program.
Transl Lung Cancer Res
; 9(4): 1169-1179, 2020 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-32953495
8.
T cell receptor repertoire characteristics both before and following immunotherapy correlate with clinical response in mesothelioma.
J Immunother Cancer
; 8(1)2020 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-32234848
9.
Enhancing Dendritic Cell Therapy in Solid Tumors with Immunomodulating Conventional Treatment.
Mol Ther Oncolytics
; 13: 67-81, 2019 Jun 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-31020037
10.
A multicenter, randomized, phase II/III study of dendritic cells loaded with allogeneic tumor cell lysate (MesoPher) in subjects with mesothelioma as maintenance therapy after chemotherapy: DENdritic cell Immunotherapy for Mesothelioma (DENIM) trial.
Transl Lung Cancer Res
; 8(3): 280-285, 2019 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-31367541
11.
In Response to "Intratumor Distribution of Ki-67 Antigen Beyond Labeling Index for Clinical Decision Making: A New Way of Counting".
JTO Clin Res Rep
; 2(9): 100215, 2021 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-34734195